Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis C-Reference-Cited by-同舟云学术

Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis C

Published:2013-11-07 Issue:7 Volume:63 Page:1150-1158
ISSN:0017-5749
Container-title:Gut
language:en
Short-container-title:Gut

Author:

Colombo M,Fernández I,Abdurakhmanov D,Ferreira P A,Strasser S I,Urbanek P,Moreno C,Streinu-Cercel A,Verheyen A,Iraqi W,DeMasi R,Hill A,Läuffer J M,Lonjon-Domanec I,Wedemeyer H

Publisher

BMJ

Subject

Gastroenterology

Reference28 articles.

1. Diagnosis, management, and treatment of hepatitis C: an update;Ghany;Hepatology,2009

2. EASL clinical practice guidelines: management of hepatitis C virus infection;European Association for the Study of the Liver (EASL);J Hepatol,2011

3. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases;Ghany;Hepatology,2011

4. New Protease inhibitors and direct-acting antivirals for hepatitis C: interferon's long goodbye;Dusheiko;Gut,2012

5. Antiviral strategies in hepatitis C virus infection;Sarrazin;J Hepatol,2012

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Breakthroughs in hepatitis C research: from discovery to cure;Nature Reviews Gastroenterology & Hepatology;2022-05-20

2. Antiviral therapy of chronic hepatitis C: 30 years success story;Terapevticheskii arkhiv;2019-11-15

3. Alternative access schemes for pharmaceuticals in Europe: Towards an emerging typology;Health Policy;2019-07

4. Interferon-Free Regimen: Equally Effective in Treatment Naive and Experienced HCV Patients;Annals of Hepatology;2019-01

5. Predictors of early discontinuation of interferon-free direct antiviral agents in patients with hepatitis C virus and advanced liver fibrosis;European Journal of Gastroenterology & Hepatology;2017-10